Improving protein analysis for Alzheimer's research

Soft-Landing of Size-Separated Macromolecules for Structural Analysis by Cryo-TEM

NIH-funded research Nanoengineering Corporation · NIH-11069565

This study is looking at how proteins related to Alzheimer's disease are structured, using new techniques to help scientists see them better, which could lead to new treatments for the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNanoengineering Corporation NIH-funded
Lab location1 site (Boca Raton, United States)
Project IDNIH-11069565 on NIH RePORTER

What this research studies

This research focuses on enhancing the analysis of protein structures related to Alzheimer's disease using advanced techniques. By employing a method called 'soft-landing,' the researchers aim to separate proteins by size and deposit them onto a sample grid for detailed imaging. This approach utilizes native mass spectrometry and a novel separation technology to preserve protein structures, which is crucial for understanding their role in Alzheimer's. The collaboration between NanoEngineering Corporation and the University of Michigan aims to overcome existing challenges in protein analysis, potentially leading to breakthroughs in drug discovery.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals affected by Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for Alzheimer's disease by providing insights into protein structures involved in the condition.

How similar studies have performed: Previous research has shown promise in using advanced mass spectrometry techniques for protein analysis, indicating potential success for this novel approach.

Where this research is happening

Boca Raton, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.